Pharmacists told to warn women of Valproate risks
STRENGTHENED warnings about the prescribing of the medicine Valproate — which has been linked to birth defects — have been issued to pharmacists.
The Pharmaceutical Society of Ireland, which regulates pharmacists, said they must inform women of childbearing age of the potential risk of abnormal pregnancy outcomes when supplying medicines containing Valproate.
The drug is used in the management of epilepsy or bipolar disorder.
Pharmacists need to provide counselling and including a leaflet and alert card with each supply of these medicines.
Niall Byrne, Registrar of the Pharmaceutical Society said: “We cannot overstate the importance of informing patients of the risks associated with medicines containing Valproate, which are used in the treatment of epilepsy and bipolar disorder.”
The latest notice has been issued following new recommendations from the Pharmacovigilance Risk Assessment Committee this month.